Crinetics Pharmaceuticals, Inc.
CRNX
$35.70
-$0.35-0.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -24.09% | 26.62% | 38.64% | 41.42% | 142.42% |
| Total Receivables | -- | -- | -- | -21.57% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -14.31% | 366.72% | 373.85% | 85.64% | 356.46% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -73.40% | -80.28% | 6.20% | -71.85% |
| Total Current Assets | -23.78% | 27.77% | 39.15% | 40.76% | 139.55% |
|
|
|||||
| Total Current Assets | -23.78% | 27.77% | 39.15% | 40.76% | 139.55% |
| Net Property, Plant & Equipment | -1.42% | -0.81% | -1.20% | -4.00% | -3.23% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 482.17% | 961.95% | 947.80% | 896.15% | 9.97% |
| Total Assets | -21.49% | 27.59% | 37.84% | 39.17% | 125.79% |
|
|
|||||
| Total Accounts Payable | 286.31% | 23.69% | 27.65% | -8.50% | -10.61% |
| Total Accrued Expenses | 23.00% | 52.64% | 36.85% | 28.66% | 62.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -9.27% | -13.11% | -11.22% | 18.84% | 71.39% |
| Total Finance Division Other Current Liabilities | -43.24% | -14.75% | -26.17% | -59.06% | -62.94% |
| Total Other Current Liabilities | -43.24% | -14.75% | -26.17% | -59.06% | -62.94% |
| Total Current Liabilities | 42.54% | 38.45% | 25.78% | 10.71% | 35.82% |
|
|
|||||
| Total Current Liabilities | 42.54% | 38.45% | 25.78% | 10.71% | 35.82% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.65% | -5.37% | -5.55% | -5.94% | -6.28% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 27.42% | 22.75% | 39.89% | 28.24% | 16.48% |
| Total Liabilities | 22.21% | 18.65% | 12.67% | 3.98% | 14.07% |
|
|
|||||
| Common Stock & APIC | 5.79% | 38.90% | 43.61% | 44.22% | 90.96% |
| Retained Earnings | -48.87% | -48.55% | -46.54% | -45.55% | -45.65% |
| Treasury Stock & Other | 82.04% | 2.16% | 894.21% | 1,234.67% | -1.43% |
| Total Common Equity | -25.11% | 28.71% | 41.02% | 43.33% | 145.74% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -25.11% | 28.71% | 41.02% | 43.33% | 145.74% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -25.11% | 28.71% | 41.02% | 43.33% | 145.74% |
|
|
|||||